Please wait while the formulary information is being retrieved.
AMBISOME (AMPHOTERICIN B LIPOSOME)
- Candida peritonitis
- Candidal meningitis
- Candidal septicemia
- Candidemia
- Candidiasis
- Cryptococcal meningitis in HIV
- Cryptococcal septicemia
- Cryptococcosis
- Disseminated candidiasis
- Febrile neutropenic patient presumed infection treatment
- Fungal sepsis
- Refractory aspergillosis
- Visceral leishmaniasis
50 mg intravenous suspension
- Infuse 4 mg/kg over 60-120 minute(s) by intravenous route once daily
Candida peritonitis
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Candidal meningitis
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Candidal septicemia
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Candidemia
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Candidiasis
- Infuse 3 mg/kg by intravenous route once daily
- Infuse 4 mg/kg by intravenous route once daily
- Infuse 5 mg/kg by intravenous route once daily
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 4 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Cryptococcal septicemia
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Cryptococcosis
- Infuse 3 mg/kg by intravenous route once daily
- Infuse 4 mg/kg by intravenous route once daily
- Infuse 5 mg/kg by intravenous route once daily
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 4 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Disseminated candidiasis
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Febrile neutropenic patient presumed infection treatment
- Infuse 3 mg/kg by intravenous route once daily
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
Fungal sepsis
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Refractory aspergillosis
- Infuse 3 mg/kg by intravenous route once daily
- Infuse 4 mg/kg by intravenous route once daily
- Infuse 5 mg/kg by intravenous route once daily
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 4 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 5 mg/kg over 60-120 minute(s) by intravenous route once daily
Visceral leishmaniasis
- Infuse 3 mg/kg by intravenous route once daily
- Infuse 4 mg/kg by intravenous route once daily
- Infuse 3 mg/kg over 60-120 minute(s) by intravenous route once daily
- Infuse 4 mg/kg over 60-120 minute(s) by intravenous route once daily
- cidofovir
- Vistide
Contraindicated
- A-hydrocort
- A-methapred
- Acthar H.p.
- Anucort-hc
- Anusol-hc
- Aristospan Intra-articular
- Aristospan Intralesional
- betamethasone acet & sod phos
- budesonide
- Celestone Soluspan
- clozapine
- Clozaril
- Colocort
- Cortef
- Cortenema
- corticotropin
- Cortifoam
- cortisone
- cyclosporine
- cyclosporine modified
- deferiprone
- Depo-medrol
- dexamethasone
- Dexamethasone Intensol
- dexamethasone sodium phos (PF)
- dexamethasone sodium phosphate
- Dexpak 10 Day
- Dexpak 13 Day
- Dexpak 6 Day
- Digox
- digoxin
- Entocort Ec
- Ez Use Joint-tunnel-trigger
- Fazaclo
- Ferriprox
- First-duke's
- First-mary's Mouthwash
- Flo-pred
- Gengraf
- Grx Hicort 25
- Hemril-30
- hydrocortisone
- hydrocortisone acetate
- hydrocortisone sod succ (PF)
- hydrocortisone sod succinate
- Kenalog
- Lanoxin
- Lanoxin Pediatric
- Medrol
- Medrol (pak)
- methylprednisolone
- methylprednisolone acetate
- methylprednisolone sod suc(PF)
- methylprednisolone sodium succ
- methylprednisolone-bupivacaine
- Millipred
- Millipred Dp
- Neoral
- nystatin-hydrocortisone-diphen
- nystatin-TCN-HC-diphenhydramin
- Orapred
- Orapred Odt
- Pediapred
- Physicians Ez Use M-pred
- prednisolone
- prednisolone acetate
- prednisolone sodium phosphate
- prednisone
- Prednisone Intensol
- Proctocort
- Rayos
- Rectacort-hc
- Sandimmune
- Solu-cortef
- Solu-cortef (pf)
- Solu-medrol
- Solu-medrol (pf)
- triamcinolone acetonide
- triamcinolone hexacetonide
- triamcinolone-lidocaine
- Uceris
- Veripred 20
- Versacloz
Severe
Moderate
- adefovir
- Atripla
- Complera
- efavirenz-emtricitabin-tenofov
- elvitegr-cobicist-emtric-tenof
- emtricitab-rilpivirine-tenofov
- emtricitabine-tenofovir
- gentamicin
- gentamicin in NaCl (iso-osm)
- gentamicin sulfate (ped) (PF)
- gentamicin sulfate (PF)
- Hepsera
- Stribild
- tenofovir disoproxil fumarate
- Truvada
- Viread
- None
Contraindicated
- Hypokalemia
- Hypomagnesemia
- Systemic mastocytosis
Severe
Moderate
- Kidney disease with reduction in GFR
AMBISOME (AMPHOTERICIN B LIPOSOME)
- Candida peritonitis
- Candidal meningitis
- Candidal septicemia
- Candidemia
- Candidiasis
- Cryptococcal meningitis in HIV
- Cryptococcal septicemia
- Cryptococcosis
- Disseminated candidiasis
- Febrile neutropenic patient presumed infection treatment
- Fungal sepsis
- Refractory aspergillosis
- Visceral leishmaniasis
- Chills
- Fever
- Hypokalemia
- Abdominal pain with cramps
- Diarrhea
- Headache disorder
- Nausea
- Vomiting
More Frequent
Severe
Less Severe
- Back pain
- Chest pain
- Dyspnea
- Jaundice
- Skin rash
- Urine discoloration
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute renal failure
- Agranulocytosis
- Anaphylaxis
- Angioedema
- Hemorrhagic cystitis
- Hypoventilation
- Pulmonary edema
- Rhabdomyolysis
Less Severe
- Abnormal vaginal bleeding
- Dysuria
- Erythema
- Kidney disease with reduction in GFR
- Urinary incontinence
- Urticaria
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Amphotericin B liposomal
Safety and efficacy not established age < 1 month.
- 1 Day – 29 Days
- Safety and efficacy not established age < 1 month.
Amphotericin B Liposome
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Amphotericin B Liposome
Insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Candida peritonitis | |
| B37.89 | Other sites of candidiasis |
| K65.0 | Generalized (acute) peritonitis |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
| Candidal meningitis | |
| B37.5 | Candidal meningitis |
| Candidal septicemia | |
| B37.7 | Candidal sepsis |
| Candidemia | |
| B37.7 | Candidal sepsis |
| Candidiasis | |
| B37 | Candidiasis |
| B37.0 | Candidal stomatitis |
| B37.1 | Pulmonary candidiasis |
| B37.2 | Candidiasis of skin and nail |
| B37.3 | Candidiasis of vulva and vagina |
| B37.4 | Candidiasis of other urogenital sites |
| B37.41 | Candidal cystitis and urethritis |
| B37.42 | Candidal balanitis |
| B37.49 | Other urogenital candidiasis |
| B37.5 | Candidal meningitis |
| B37.6 | Candidal endocarditis |
| B37.7 | Candidal sepsis |
| B37.8 | Candidiasis of other sites |
| B37.81 | Candidal esophagitis |
| B37.82 | Candidal enteritis |
| B37.83 | Candidal cheilitis |
| B37.84 | Candidal otitis externa |
| B37.89 | Other sites of candidiasis |
| B37.9 | Candidiasis, unspecified |
| P37.5 | Neonatal candidiasis |
| Cryptococcal meningitis in HIV | |
| B45.1 | Cerebral cryptococcosis |
| Cryptococcal septicemia | |
| B45.7 | Disseminated cryptococcosis |
| Cryptococcosis | |
| B45 | Cryptococcosis |
| B45.0 | Pulmonary cryptococcosis |
| B45.1 | Cerebral cryptococcosis |
| B45.2 | Cutaneous cryptococcosis |
| B45.3 | Osseous cryptococcosis |
| B45.7 | Disseminated cryptococcosis |
| B45.8 | Other forms of cryptococcosis |
| B45.9 | Cryptococcosis, unspecified |
| Disseminated candidiasis | |
| B37.5 | Candidal meningitis |
| B37.6 | Candidal endocarditis |
| B37.7 | Candidal sepsis |
| B37.89 | Other sites of candidiasis |
| Febrile neutropenic patient presumed infection treatment | |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
| D70.2 | Other drug-induced agranulocytosis |
| D70.3 | Neutropenia due to infection |
| D70.8 | Other neutropenia |
| D70.9 | Neutropenia, unspecified |
| R50.81 | Fever presenting with conditions classified elsewhere |
| Fungal sepsis | |
| B37.7 | Candidal sepsis |
| B44.7 | Disseminated aspergillosis |
| Refractory aspergillosis | |
| B44 | Aspergillosis |
| B44.0 | Invasive pulmonary aspergillosis |
| B44.1 | Other pulmonary aspergillosis |
| B44.2 | Tonsillar aspergillosis |
| B44.7 | Disseminated aspergillosis |
| B44.89 | Other forms of aspergillosis |
| B44.9 | Aspergillosis, unspecified |
| Visceral leishmaniasis | |
| B55.0 | Visceral leishmaniasis |
| 0-9 | A-Z |
|---|---|
| B37 | Candidiasis |
| B37.0 | Candidal stomatitis |
| B37.1 | Pulmonary candidiasis |
| B37.2 | Candidiasis of skin and nail |
| B37.3 | Candidiasis of vulva and vagina |
| B37.4 | Candidiasis of other urogenital sites |
| B37.41 | Candidal cystitis and urethritis |
| B37.42 | Candidal balanitis |
| B37.49 | Other urogenital candidiasis |
| B37.5 | Candidal meningitis |
| B37.5 | Candidal meningitis |
| B37.5 | Candidal meningitis |
| B37.6 | Candidal endocarditis |
| B37.6 | Candidal endocarditis |
| B37.7 | Candidal sepsis |
| B37.7 | Candidal sepsis |
| B37.7 | Candidal sepsis |
| B37.7 | Candidal sepsis |
| B37.7 | Candidal sepsis |
| B37.8 | Candidiasis of other sites |
| B37.81 | Candidal esophagitis |
| B37.82 | Candidal enteritis |
| B37.83 | Candidal cheilitis |
| B37.84 | Candidal otitis externa |
| B37.89 | Other sites of candidiasis |
| B37.89 | Other sites of candidiasis |
| B37.89 | Other sites of candidiasis |
| B37.9 | Candidiasis, unspecified |
| B44 | Aspergillosis |
| B44.0 | Invasive pulmonary aspergillosis |
| B44.1 | Other pulmonary aspergillosis |
| B44.2 | Tonsillar aspergillosis |
| B44.7 | Disseminated aspergillosis |
| B44.7 | Disseminated aspergillosis |
| B44.89 | Other forms of aspergillosis |
| B44.9 | Aspergillosis, unspecified |
| B45 | Cryptococcosis |
| B45.0 | Pulmonary cryptococcosis |
| B45.1 | Cerebral cryptococcosis |
| B45.1 | Cerebral cryptococcosis |
| B45.2 | Cutaneous cryptococcosis |
| B45.3 | Osseous cryptococcosis |
| B45.7 | Disseminated cryptococcosis |
| B45.7 | Disseminated cryptococcosis |
| B45.8 | Other forms of cryptococcosis |
| B45.9 | Cryptococcosis, unspecified |
| B55.0 | Visceral leishmaniasis |
| D70.1 | Agranulocytosis secondary to cancer chemotherapy |
| D70.2 | Other drug-induced agranulocytosis |
| D70.3 | Neutropenia due to infection |
| D70.8 | Other neutropenia |
| D70.9 | Neutropenia, unspecified |
| K65.0 | Generalized (acute) peritonitis |
| P37.5 | Neonatal candidiasis |
| R50.81 | Fever presenting with conditions classified elsewhere |
| T85.71 | Infection and inflammatory reaction due to peritoneal dialysis catheter |
| T85.71xA | Infection and inflammatory reaction due to peritoneal dialysis catheter, initial encounter |
Formulary Reference Tool